These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2149919)

  • 21. In vitro activity of several antimicrobial agents against genital mycoplasmas.
    Echániz Avilés G; Conde González C; Juárez Figueroa L; Carnalla Barajas N; Tamayo Legorreta E; Calderón Jaimes E
    Clin Ther; 1992; 14(5):688-95. PubMed ID: 1468088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of trospectomycin, a new aminocyclitol antibiotic, against multidrug-resistant Enterococcus faecium.
    Mobarakai N; Landman D; Quale JM
    J Antimicrob Chemother; 1994 Feb; 33(2):319-21. PubMed ID: 8182013
    [No Abstract]   [Full Text] [Related]  

  • 23. In-vitro activities of trospectomycin, cefpodoxime, and second-generation cephalosporins against Haemophilus influenzae type b.
    LiPuma JJ; Daley B; Stull TL
    J Antimicrob Chemother; 1990 Apr; 25(4):535-9. PubMed ID: 2141018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of serum bactericidal activity by paldimycin.
    Cialdella JI; Ulrich RG; Marshall VP
    J Antibiot (Tokyo); 1988 May; 41(5):660-6. PubMed ID: 3384752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of 250 mg trospectomycin sulfate i.m. vs. 250 mg ceftriaxone i.m. for treatment of uncomplicated gonorrhea.
    Rompalo AM; Colletta L; Caine VA; Linnemeier P; Neumann T; Hook EW; Jones RB
    Sex Transm Dis; 1994; 21(4):213-6. PubMed ID: 7974072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of a new antibacterial drug, trospectomycin sulphate (U-63,366F), against Bacteroides strains isolated from the vagina.
    Testore GP; Terranova L; Salanitro A; Sordillo P; Foli A; Giacomello F; Andreoni M
    Chemotherapy; 1993; 39(2):124-7. PubMed ID: 8458245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shape Changes and Interaction Mechanism of Escherichia coli Cells Treated with Sericin and Use of a Sericin-Based Hydrogel for Wound Healing.
    Xue R; Liu Y; Zhang Q; Liang C; Qin H; Liu P; Wang K; Zhang X; Chen L; Wei Y
    Appl Environ Microbiol; 2016 Aug; 82(15):4663-4672. PubMed ID: 27235427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue fluid penetration and anti-treponemal activity of trospectomycin (a new spectinomycin analog) in the rabbit syphilis model.
    Rice RJ; Thompson SE; Arko RJ; Hunter EF; Burleigh PM; Craig BT; Larsen SA
    Sex Transm Dis; 1988; 15(3):152-5. PubMed ID: 2976206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro susceptibility of Helicobacter pylori to trospectomycin, pirlimycin (U-57930E), mirincamycin (U-24729A) and N-demethyl clindamycin (U-26767A).
    Westblom TU; Midkiff BR; Czinn SJ
    Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):560-2. PubMed ID: 8404921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefmetazole and trospectomycin in vitro susceptibility testing interpretive criteria and quality control guidelines for Neisseria gonorrheae.
    Jones RN; Erwin ME; Washington JA; Koontz FP; Murray PR; Gerlach EH
    Diagn Microbiol Infect Dis; 1992; 15(7):627-32. PubMed ID: 1424520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents.
    Debets-Ossenkopp YJ; Namavar F; MacLaren DM
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):353-5. PubMed ID: 7649202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of gonococcal infections with a single 250 mg intramuscular injection of trospectomycin sulphate vs ceftriaxone sodium.
    Mroczkowski TF; Millikan LE; Martin DH; Leonik KJ
    Drugs Exp Clin Res; 1993; 19(1):41-6. PubMed ID: 8223139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple-dose, double-blind, placebo controlled intravenous tolerance and pharmacokinetic study of trospectomycin sulfate (U-63, 366F) in healthy male volunteers.
    Peters GR; Novak E; Batts DH; Bye A; Nichols DJ; Francom SF
    Int J Clin Pharmacol Ther Toxicol; 1990 Sep; 28(9):361-8. PubMed ID: 2146231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased phagocytosis and killing of Escherichia coli treated with subinhibitory concentrations of cefamandole and gentamicin in isolated rat livers.
    Andreana A; Perna P; Utili R; Dilillo M; Ruggiero G
    Antimicrob Agents Chemother; 1984 Feb; 25(2):182-6. PubMed ID: 6370126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
    Vaara M; Viljanen P; Vaara T; Mäkelä PH
    J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro activities of 9 aminosides against of 250 strains of Neisseria gonorrhoeae].
    Casin I; Sanson-Le Pors MJ; Barateau V; Morel P; Perol Y
    Pathol Biol (Paris); 1987 May; 35(5):517-20. PubMed ID: 3112706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
    Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trospectomycin, a novel spectinomycin analogue: antibacterial activity and preliminary human pharmacokinetics.
    Zurenko GE; Ford CW; Novak E
    Drugs Exp Clin Res; 1988; 14(6):403-9. PubMed ID: 2975212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains.
    Veringa E; Box A; Rozenberg-Arska M; Verhoef J
    Drugs Exp Clin Res; 1988; 14(1):1-8. PubMed ID: 3292179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.
    Schreiber RD; Morrison DC; Podack ER; Müller-Eberhard HJ
    J Exp Med; 1979 Apr; 149(4):870-82. PubMed ID: 372483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.